search
Back to results

Trial Comparing Loop Ileostomy Versus Loop Transverse Colostomy (LIVELOC)

Primary Purpose

Rectal Neoplasms, Ostomy, Neoplasms

Status
Recruiting
Phase
Not Applicable
Locations
Russian Federation
Study Type
Interventional
Intervention
Laparoscopic or open low-anterior resection of the rectum with TME and created loop transverse colostomy
Laparoscopic or open low-anterior resection of the rectum with TME and created loop ileostomy
Sponsored by
Republican Clinical Oncological Dispensary, Ministry of Health of the Republic of Bashkortostan
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Rectal Neoplasms focused on measuring Rectal cancer, Low anterior resection, Loop transverse colostomy, Loop ileostomy, Stoma site infections

Eligibility Criteria

18 Years - 79 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Histologically confirmed adenocarcinoma of the rectum (stages 1-3 according to MRI) ECOG status 0-2, ASA≤3. At least 18 years of age Written informed consent Exclusion Criteria: Emergency surgery; Previously formed stoma; Stage 4 disease; Obstructive resection of the rectum; Patients older than 79 years

Sites / Locations

  • Republican clinical oncological dispenceryRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Loop transverse colostomy

Loop ileostomy

Arm Description

Laparoscopic or open low-anterior resection of the rectum with total mesorectal excision and created loop transverse colostomy

Laparoscopic or open low-anterior resection of the rectum with total mesorectal excision and created loop ileostomy

Outcomes

Primary Outcome Measures

SSI
incidence of stoma site infections
Ileus
incidence of stoma dysfunction

Secondary Outcome Measures

Readmission rate
readmission rate
Length of hospital stay
the number of days from surgery to discharge
Time to stoma closure
the number of days from surgery to stoma closure
Time to first stool
the occurrence of anything other than serous-hemorrhagic contents in the colostomy bag
Time to adjuvant postoperative chemotherapy
the number of days from surgery to hospitalization for first chemotherapy
Quality of life in patients with ostomy
estimated using EORTC QLQ-CR29

Full Information

First Posted
February 4, 2023
Last Updated
April 15, 2023
Sponsor
Republican Clinical Oncological Dispensary, Ministry of Health of the Republic of Bashkortostan
search

1. Study Identification

Unique Protocol Identification Number
NCT05745909
Brief Title
Trial Comparing Loop Ileostomy Versus Loop Transverse Colostomy
Acronym
LIVELOC
Official Title
Randomized Single Center Clinical Trial Comparing Loop Ileostomy Versus Loop Transverse Colostomy in Patients After Major Anterior Resections
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 1, 2023 (Actual)
Primary Completion Date
March 1, 2024 (Anticipated)
Study Completion Date
March 1, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Republican Clinical Oncological Dispensary, Ministry of Health of the Republic of Bashkortostan

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine which stoma creation technique is preferable after low anterior resection of the rectum.
Detailed Description
The investigators enroll patients with a histologically confirmed diagnosis of primary rectal cancer with or without prior chemoradiotherapy who were hospitalized at the Ufa Republican Clinical Oncology Center from February 2023 to February 2024. All patients undergo planned laparoscopic or open low-anterior resection of the rectum with total mesorectal excision. Patients are randomized into 2 groups in a 1:1 ratio. In the first group, a loop transverse colostomy is created, and in the second group, a loop ileostomy is created. The stoma exit sites are marked in advance the day before the surgery. The bowels are prepared by mechanical means (a polyethylene glycol-based laxative with a cleansing enema) according to a standard procedure before the surgery. Standardized stoma creation techniques are used. The resected parts are collected through a separate access. Patients are followed up for 60 days after surgery. The sample size should be 124 patients to reach statistical significance (α = 0.05, study power 80%, confidence interval (CI) = 95%.). Considering possible losses during the study, the number of patients was increased to 130. The investigators hypothesis is that the loop ileostomy group has a 20% higher incidence of stoma dysfunction but a 20% lower incidence of SSI (stoma site infections) compared to the loop colostomy group.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rectal Neoplasms, Ostomy, Neoplasms
Keywords
Rectal cancer, Low anterior resection, Loop transverse colostomy, Loop ileostomy, Stoma site infections

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
130 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Loop transverse colostomy
Arm Type
Active Comparator
Arm Description
Laparoscopic or open low-anterior resection of the rectum with total mesorectal excision and created loop transverse colostomy
Arm Title
Loop ileostomy
Arm Type
Experimental
Arm Description
Laparoscopic or open low-anterior resection of the rectum with total mesorectal excision and created loop ileostomy
Intervention Type
Procedure
Intervention Name(s)
Laparoscopic or open low-anterior resection of the rectum with TME and created loop transverse colostomy
Intervention Description
The loop transverse colostomy is matured without torsion using a plastic retainer. The stoma protrudes 2-3 cm. The loop of the transverse colon is sutured with interrupted sutures using an absorbable 3/0 polyglactin suture without piercing the intestinal wall. The intestinal lumen is opened through a transverse incision on the antimesenteric border.
Intervention Type
Procedure
Intervention Name(s)
Laparoscopic or open low-anterior resection of the rectum with TME and created loop ileostomy
Intervention Description
The loop ileostomy is matured 25-30 cm from the ileocecal angle without torsion and without a retainer, so that stoma protrudes 2-3 cm. The loop of the ileum is sutured with interrupted sutures using an absorbable 3/0 polyglactin suture without piercing the intestinal wall. The intestinal lumen is opened through a transverse incision on the antimesenteric border.
Primary Outcome Measure Information:
Title
SSI
Description
incidence of stoma site infections
Time Frame
60 days after surgery
Title
Ileus
Description
incidence of stoma dysfunction
Time Frame
60 days after surgery
Secondary Outcome Measure Information:
Title
Readmission rate
Description
readmission rate
Time Frame
within the first 60 days after surgery
Title
Length of hospital stay
Description
the number of days from surgery to discharge
Time Frame
From date of surgery until the date of discharge, assessed up to 60 days
Title
Time to stoma closure
Description
the number of days from surgery to stoma closure
Time Frame
within the first 6 months days after surgery
Title
Time to first stool
Description
the occurrence of anything other than serous-hemorrhagic contents in the colostomy bag
Time Frame
60 days after surgery
Title
Time to adjuvant postoperative chemotherapy
Description
the number of days from surgery to hospitalization for first chemotherapy
Time Frame
within the first 2 months days after surgery
Title
Quality of life in patients with ostomy
Description
estimated using EORTC QLQ-CR29
Time Frame
within the first 60 days after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
79 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Histologically confirmed adenocarcinoma of the rectum (stages 1-3 according to MRI) ECOG status 0-2, ASA≤3. At least 18 years of age Written informed consent Exclusion Criteria: Emergency surgery; Previously formed stoma; Stage 4 disease; Obstructive resection of the rectum; Patients older than 79 years
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Rustem Aupov
Phone
+79173448501
Email
ru2003@bk.ru
Facility Information:
Facility Name
Republican clinical oncological dispencery
City
Ufa
State/Province
Republic Of Bashkortostan
ZIP/Postal Code
450054
Country
Russian Federation
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rustem Aupov
Phone
+79173448501
Email
ru2003@bk.ru

12. IPD Sharing Statement

Learn more about this trial

Trial Comparing Loop Ileostomy Versus Loop Transverse Colostomy

We'll reach out to this number within 24 hrs